Dermatology clinical trials recruiting in Illinois

28 recruiting dermatology trials match in Illinois. Showing 20.

• A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruiting

  Phase 3 · Takeda · Rolling Meadows, Illinois

• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisRecruiting

  Phase 3 · AbbVie · Chicago, Illinois

• A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With VitiligoRecruiting

  Phase 1 · Teva Branded Pharmaceutical Products R&D LLC · Hot Springs, Arkansas

• An Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Rolling Meadows, Illinois

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Apollo Therapeutics Ltd · Birmingham, Alabama

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)Recruiting

  Phase 3 · Bristol-Myers Squibb · Skokie, Illinois

• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisRecruiting

  Phase 2 · Apogee Therapeutics, Inc. · Skokie, Illinois

• Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic DermatitisRecruiting

  Phase 4 · Northwestern University · Chicago, Illinois

• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 3 · Nektar Therapeutics · Normal, Illinois

• Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)Recruiting

  Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID) · Chicago, Illinois

• A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · Janssen Research & Development, LLC · Willowbrook, Illinois

• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabRecruiting

  Phase 3 · AbbVie · Chicago, Illinois

• Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · AbbVie · Skokie, Illinois

• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruiting

  Phase 1 · National Cancer Institute (NCI) · Sacramento, California

• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Rolling Meadows, Illinois

• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcneRecruiting

  Phase 1 / Phase 2 · Sanofi Pasteur, a Sanofi Company · Chicago, Illinois

• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesRecruiting

  Phase 3 · Takeda · Mesa, Arizona

• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesRecruiting

  Phase 3 · Takeda · Orland Park, Illinois

• Observational Study of Pediatric Rheumatic Diseases: The CARRA RegistryRecruiting

  N/A · Duke University · Chicago, Illinois

• Study of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Enveda Therapeutics · Chicago, Illinois

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.